| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ATP binding cassette subfamily C member 11 | 0.565 | 0.769 | 4.0E-46 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
abl interactor 1 | 0.641 | 0.538 | 0.64 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2001 | ||||||||
|
abl interactor 2 | 0.700 | 0.423 | 0.43 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.966 | 59 | 1 | 1987 | 2020 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2002 | 2002 | ||||||||
|
atypical chemokine receptor 3 | 0.428 | 0.885 | 0.39 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1994 | 2004 | ||||||||
|
activin A receptor type 1 | 0.535 | 0.731 | 0.33 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
adhesion G protein-coupled receptor G1 | 0.590 | 0.654 | 5.3E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
adrenoceptor alpha 1A | 0.462 | 0.846 | 3.4E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
adrenoceptor alpha 2B | 0.465 | 0.846 | 4.5E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
afadin, adherens junction formation factor | 0.650 | 0.462 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
AF4/FMR2 family member 1 | 0.659 | 0.423 | 0.71 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
ArfGAP with FG repeats 1 | 0.569 | 0.769 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2006 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2004 | 2018 | ||||||||
|
allograft inflammatory factor 1 like | 0.821 | 0.192 | 6.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
aldo-keto reductase family 1 member C3 | 0.529 | 0.769 | 7.6E-24 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2009 | 2020 | ||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 |